Form 4: Zomedica Corp. CFO Peter Donato Acquires 2.5 Million Stock Options
SEC Form 4 Filing
Peter Donato, CFO of Zomedica Corp., reports the acquisition of 2,500,000 stock options with an exercise price of $0.14 on May 13, 2024.
Summary
- On May 13, 2024, Peter Donato, the Chief Financial Officer of Zomedica Corp., acquired 2,500,000 options to buy common stock.
- The exercise price for these options is $0.14.
- The options vest annually in four equal installments starting on May 13, 2025.
- Following the transaction, Donato directly owns 2,500,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing regarding stock option grants, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock option grants to a company executive, which is a common practice in publicly traded companies to incentivize and retain key personnel.
Stakeholder Impact
- The acquisition of stock options by the CFO may incentivize him to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of transaction: Peter Donato acquired 2,500,000 stock options. |
| 05/13/2025 | Vesting start date: The stock options vest annually in four equal installments commencing on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.